1-3 of 3
Kirsten Heitmann
Close
Sort by
Journal Articles

mTOR Pathway Links Suppressed Autophagy to HDAC Inhibitor-Induced Apoptosis in Myeloid Leukemia,

Metodi V. Stankov, PhD, Kirsten Heitmann, Zhe Li, PhD, Basant Kumar Thakur, PhD, Diana Panayotova-Dimitrova, PhD, Jennifer Schòˆning, Jean-Pierre Bourquin, MD, PhD, Tino Dittrich, Stephan Emmrich, Nora Schweitzer, MD, Martin Leverkus, MD, Dirk Reinhardt, MD, PhD, Stuart H. Orkin, MD, Georg M.N. Behrens, MD, Jan-Henning Klusmann, MD
Journal: Blood
Blood (2011) 118 (21): 3614.
https://doi.org/10.1182/blood.V118.21.3614.3614
Published: 2011
Journal Articles

Gene Expression-Based Chemical Genomics Identifies Valproic Acid to Revert the Oncogenic Effect of GATA1s In Down Syndrome Megakaryoblastic Leukemia.

Kirsten Heitmann, Zhe Li, PhD, Jan-Henning Klusmann, MD, Basant Kumar Thakur, PhD, Jennifer Schòˆning, Jean-Pierre Bourquin, MD, PhD, Stuart H. Orkin, MD, Dirk Reinhardt, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3646.
https://doi.org/10.1182/blood.V116.21.3646.3646
Published: 2010
Journal Articles

Developmental Stage-Specific Interplay Between GATA1 and IGF Signaling in Fetal Hematopoiesis and Leukemogenesis.

Jan-Henning Klusmann, MD, Frank Godinho, Kirsten Heitmann, Aliaksandra Maroz, Dirk Reinhardt, MD, PhD, Stuart H Orkin, MD, Zhe Li, PhD
Journal: Blood
Blood (2009) 114 (22): 386.
https://doi.org/10.1182/blood.V114.22.386.386
Published: 2009